MedTrace Logo

Does Routine Screening for Intimate Partner Violence Against Women in Health Care Settings do More Good Than Harm?

NCT00182468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5681

Last updated 2009-09-09

No results posted yet for this study

Summary

The purpose of the research is to evaluate whether routine screening for woman abuse in health care settings, as compared to no screening, does more good than harm. Recent reviews have identified the need for high quality research to understand 1) the actual impact on all women of instituting mass screening procedures to identify woman abuse and 2) the extent to which early identification through screening is effective in preventing or ameliorating important outcomes. The main outcomes for the study are reduction in violence, improvement in life quality, and potential harms of screening. A number of secondary outcomes to help understand the process by which screening and usual care might lead to changes in the primary outcomes will also be assessed.

Conditions

  • Intimate Partner Violence Against Women

Interventions

OTHER

Screening for intimate partner violence

Women are screened for intimate partner violence prior to seeing a health care provider.

Sponsors & Collaborators

  • Echo: Improving Women's Health in Ontario (formerly Ontario Women's Health Council)

    collaborator UNKNOWN

  • McMaster University

    lead OTHER

Principal Investigators

  • Harriet L MacMillan, MD, MSc · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182468 on ClinicalTrials.gov